Connected profiles3
Exact peptide identities attached to retained registry observations carrying this condition label.
Coverage-gated living condition brief
Healthy peptide evidence brief
A cited Healthy peptide evidence brief across 5 exact-label ClinicalTrials.gov records, 3 connected profiles, and 3 registry-update years. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
5 selected records.
Connected peptides
3 profiles.
Registry update years
2014–2018 in selected records.
Direct collection answer · published August 17, 2026
What peptide evidence does PeptideScanner carry for Healthy?
PeptideScanner’s selected collection contains 5 retained ClinicalTrials.gov records carrying the exact condition label “Healthy,” connected to 3 peptide profiles across 3 registry-update years.
That answer describes this collection and the exact cited registry observations below. It is not a conclusion about whether any peptide treats Healthy, and it is not a safety or efficacy assessment.
Indication intelligence
Selected evidence landscape
Trial phases1
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 1 (5)
Registry statuses1
Overall statuses at each retained observation, not necessarily current today.
Completed (5)
Across the connected peptide profiles, PeptideScanner also carries 173 selected PubMed records and 19 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Healthy unless their own cited source says so.
Related profile context
Literature connected through these peptide profiles
This is a bounded sample of up to six PubMed bibliography records connected through peptide profiles on this hub, not the total profile literature count above. They are not condition-matched records, and their presence does not establish that they concern Healthy.
Semaglutide · source record 2026-08-15
Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.
PubMed lists PMID 42602345 in Canadian journal of kidney health and disease as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Afamelanotide · source record 2026-01-18
From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.
PubMed lists PMID 41542313 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Liraglutide · source record 2026-08-14
Treatment of obesity with liraglutide in bipolar disorder: a case report.
PubMed lists PMID 42597211 in Frontiers in psychiatry as Case Reports, Journal Article, with publication-date metadata of 2026-07-30 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Semaglutide · source record 2026-08-13
Semaglutide and Non-arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Narrative Synthesis.
PubMed lists PMID 41938304 in AACE endocrinology and diabetes as Journal Article, Review, with publication-date metadata of 2026-01-17 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Afamelanotide · source record 2025-10-27
Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective.
PubMed lists PMID 40692281 in Clinical and experimental dermatology as Journal Article, with publication-date metadata of 2025-10-27 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Liraglutide · source record 2026-08-13
Application of the OBIMAP (One-Bead Interchain Multipeptide Assembly Platform) to Long Peptide Synthesis: Liraglutide as a Case Study.
PubMed lists PMID 41970854 in ACS omega as Journal Article, with publication-date metadata of 2026-03-25 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Open attributed literature record →Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT03634137
PeptideScanner retained ClinicalTrials.gov record NCT03634137 at 2026-07-30T21:10:03.005Z. Its registry update date was 2018-08-16, and PeptideScanner's reviewed identity mapping was afamelanotide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- August 16, 2018
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT01550653
PeptideScanner retained ClinicalTrials.gov record NCT01550653 at 2026-07-30T21:54:46.545Z. Its registry update date was 2014-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- February 27, 2014
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT02022254
PeptideScanner retained ClinicalTrials.gov record NCT02022254 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-04-04, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- April 4, 2017
- Evidence lane
- Clinical trials
Exact-record source chronology
Healthy registry timeline
Years come from the last-update date on each retained ClinicalTrials.gov observation. They show source chronology, not when PeptideScanner added the record and not a continuous monitoring guarantee.
2018
3 recordsAfamelanotide · 2018-08-16
ClinicalTrials.gov record NCT03634137
Completed at the retained observation.
Open cited registry record →Semaglutide · 2018-06-13
ClinicalTrials.gov record NCT02064348
Completed at the retained observation.
Open cited registry record →Semaglutide · 2018-04-18
ClinicalTrials.gov record NCT02146079
Completed at the retained observation.
Open cited registry record →2017
1 recordSemaglutide · 2017-04-04
ClinicalTrials.gov record NCT02022254
Completed at the retained observation.
Open cited registry record →2014
1 recordLiraglutide · 2014-02-27
ClinicalTrials.gov record NCT01550653
Completed at the retained observation.
Open cited registry record →- Condition matching is limited to exact labels on retained ClinicalTrials.gov v3 observations; PeptideScanner does not merge related diagnoses or synonyms.
- Coverage is selective and historical, not a complete or continuously current account of the registry or PubMed.
- The brief does not synthesize study outcomes, compare interventions, or make safety, efficacy, diagnosis, or treatment claims.